Cargando…
Progress toward a group B streptococcal vaccine
Streptococcus agalactiae (group B Streptococcus, GBS) is a leading cause of severe invasive disease in neonate, elderly, and immunocompromised patients worldwide. Despite recent advances in the diagnosis and intrapartum antibiotic prophylaxis (IAP) of GBS infections, it remains one of the most commo...
Autores principales: | Song, Joon Young, Lim, Jae Hyang, Lim, Sangyong, Yong, Zhi, Seo, Ho Seong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314413/ https://www.ncbi.nlm.nih.gov/pubmed/29995578 http://dx.doi.org/10.1080/21645515.2018.1493326 |
Ejemplares similares
-
Status of group B streptococcal vaccine development
por: Lin, Shun Mei, et al.
Publicado: (2018) -
Development and Validation of Enzyme-Linked Immunosorbent Assay for Group B Streptococcal Polysaccharide Vaccine
por: Jang, A-Yeung, et al.
Publicado: (2021) -
Molecular Characteristics of IS1216 Carrying Multidrug Resistance Gene Cluster in Serotype III/Sequence Type 19 Group B Streptococcus
por: Zhi, Yong, et al.
Publicado: (2021) -
Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With lgt Deletion
por: Jang, A-Yeung, et al.
Publicado: (2019) -
Patterns of ischemic injury on brain images in neonatal group B Streptococcal meningitis
por: Choi, Seo Yeol, et al.
Publicado: (2018)